IgG4 Neutralization and Sustained Total IgG Fc-Effector Functions Following Repeated SARS-CoV-2 mRNA Vaccination
Kaplonek, P.; Bertera, H.; Lee, D. W.; Cizmeci, D.; Yu, W.-H.; Wu, K.; Chalkias, S.; Wahid, R.; Edwards, D. K.; Alter, G.; Henry, C.
Show abstract
Detailed characterization of the antibody profile induced by SARS-CoV-2 mRNA vaccines has shown that repeat dosing boosts all IgG subclasses, with a notable emergence of antigen-specific IgG4 antibodies. While the IgG4 subclass is traditionally associated with limited Fc-effector functions, its role in SARS-CoV-2 mRNA vaccine-induced immunity remains unclear. This study tracked IgG subclass dynamics, IgG Fc-mediated functions and neutralization following immunization with two or three doses of mRNA-1273. We observed robust Spike-specific IgG1 and IgG3 responses after the primary series (two doses) and booster dose, with a significant increase in IgG4 responses after repeated dosing. Despite this rise in spike-specific IgG4 antibodies, strong Fc-effector functions were maintained at the overall IgG level, including ADCP, ADNP, and ADCD, with no antagonism from IgG4 antibodies. Additionally, IgG4 antibodies exhibited enhanced affinity and potent neutralization, complementing IgG1-driven responses. These findings suggest that the IgG4 response induced by mRNA-1273 vaccination co-evolves with other subclasses to enhance Fab- and Fc-mediated immunity, underscoring the ability of mRNA vaccines to induce a balanced, multi-subclass immune response optimized for durable protection and robust functionality.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses 98%
- BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age 97%
- Pre-existing immunity modulates responses to mRNA boosters 97%
Similar papers in this journal
- Memory B cell and humoral responses elicited by Sputnik V in naïve and COVID-19-recovered vaccine recipients 97%
- Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar. 97%
- Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA 96%
Similar papers in this journal
- Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees. 95%
- GRAd-COV2 vaccine provides potent and durable immunity in randomised placebo-controlled phase 2 trial (COVITAR) 95%
- Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects Macaques from infection 95%
Similar papers in this journal
- Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination 95%
- Preexisting memory CD4 T cells in nÏave individuals confer robust immunity upon hepatitis B vaccination 95%
- Cross-reactive antibodies after SARS-CoV-2 infection and vaccination 94%
Similar papers in this journal
- Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination 97%
- Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination 97%
- The BNT162b2 mRNA vaccine induces polyfunctional T cell responses with features of longevity. 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.